EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment



Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment



Headache 46(2): 240-252



Objective-To evaluate the psychometric properties of the revised Patient Perception of Migraine Questionnaire (PPMQ-R), which measures satisfaction with migraine treatment.Background-The original version of the PPMQ was developed prior to the introduction of newer migraine treatments, which may have attributes that influence treatment satisfaction.Methods-Literature review, patient focus groups, and one-on-one patient interviews guided revisions to the original PPMQ. The revised questionnaire was tested in 200 migraine patients visiting neurologists and primary care clinics. At baseline, all subjects completed the PPMQ-R, a migraine-specific quality-of-life measure, and a migraine experience questionnaire; and 125 subjects completed assessments 24 hours after each migraine attack and within 30 days post-baseline. Factor analysis was performed to inform the development of a scoring algorithm, and reliability, validity, and responsiveness of the PPMQ-R were evaluated.Results-Factor analyses confirmed that the revised questionnaire has five domains measuring satisfaction with efficacy, functionality, ease of use, medication cost, and bothersomeness of medication side effects. A total score can be created by taking the average of efficacy, functionality, and ease of use scores. The PPMQ-R scale scores and Total score demonstrated internal consistency reliability (Cronbach's alpha: 0.80 to 0.98) and test-retest reliability (intra-class correlation coefficient: 0.79 to 0.91). Except for the Cost domain, the PPMQ-R scores discriminated among migraine pain severity levels (all P < .05) and levels of impairment in ability to work and perform usual activities (all P < .05). Except for the Ease of Use and Cost domains, mean PPMQ-R scores were significantly higher among patients with no change in treatment and whose pain improved between two consecutive migraine attacks (all P < .01).Conclusion-The PPMQ-R is a reliable and valid measure of patient satisfaction with acute migraine treatment in women with frequent migraine attacks.

(PDF emailed within 0-6 h: $19.90)

Accession: 012734752

Download citation: RISBibTeXText

PMID: 16492233

DOI: 10.1111/j.1526-4610.2006.00289.x



Related references

Validation of the revised Patient Perception of Migraine Questionnaire (PPMQ-R): measuring satisfaction with acute migraine treatment in clinical trials. Cephalalgia 28(5): 510-523, 2008

Validation of the revised illness perception questionnaire for migraine patients and the effects of earthquake experience on perception of disease. Agri 29(1): 17-24, 2017

Validation of the Patient Perception of Migraine Questionnaire. Value in Health 5(5): 422-430, 2002

Psychometric validation of the patient perception of migraine questionnaire. Cephalalgia 20(4): 412, 2000

Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire. Current Medical Research and Opinion 20(7): 1125-1135, 2004

Validation of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v. 2.1) for patients undergoing prophylactic migraine treatment. Quality of Life Research 16(7): 1231-1237, 2007

Acute migraine medication adherence, migraine disability and patient satisfaction: A naturalistic daily diary study. Cephalalgia, 2016

The GRIM2005 study of migraine consultation in France II. Psychological factors associated with treatment response to acute headache therapy and satisfaction in migraine. Cephalalgia 27(12): 1398-1407, 2007

Validation of a new instrument for determining migraine prevalence: the UCSD Migraine Questionnaire. Neurology 44(5): 925-928, 1994

Validation of a migraine work and productivity loss questionnaire for use in migraine studies. Cephalalgia 19(5): 497-502, June, 1999

Evaluation of efficacy, tolerability, and treatment satisfaction with almotriptan in 3 consecutive migraine attacks. The migraine--satisfaction with treatment: reality with Almogran study. European Neurology 55(4): 198-203, 2006

Validation of the Korean Migraine-Specific Quality of Life Questionnaire Version 2.1 in Episodic and Chronic Migraine. Journal of Oral & Facial Pain and Headache 31(3): 251-256, 2017

How to Apply the AHS Evidence Assessment of the Acute Treatment of Migraine in Adults to your Patient with Migraine. Headache 56(7): 1194-1200, 2016

Patient satisfaction with eletriptan in the acute treatment of migraine in primary care. International Journal of Clinical Practice 61(10): 1677-1685, 2007

A satisfaction survey of current medicines used for migraine therapy in China: is Chinese patent medicine effective compared with Western medicine for the acute treatment of migraine?. Pain Medicine 15(2): 320-328, 2014